NEUROLOGICAL ADVERSE EVENTS FOLLOWING IMMUNIZATION (AEFI) ON HEALTH WORKFORCE OF A SECONDARY REFERRAL HOSPITAL IN SOUTH SULAWESI WHO RECEIVED THE
Keywords:Neurological AEFI, health workforce, COVID-19 vaccine, South Sulawesi
Background: The COVID-19 vaccination can relate to the occurrence of neurological adverse events following immunization (AEFI) that could impact work and daily activities. This problem is particularly important in the health workforce. However, little is known about neurological AEFI among the health workforce working in peripheral facilities.
Objective: To study the neurological AEFIs and their impact among the health workforce who received the COVID-19 vaccination in a secondary referral hospital in South Sulawesi, the Andi Makassau Hospital (Rumah Sakit Umum Daerah Andi Makassau/RSAM).
Methods: The COVID-19 pandemic, we created a questionnaire about neurological AEFIs and their effects which were distributed online using the Google Form application to the health workforce at the RSAM who had received at least one dose of COVID-19 vaccination.
Results: We obtained 97 subjects. There were 78.5% neurological AEFIs with the most reported type being muscle pain (16%). Most neurological AEFIs were experienced by women (84.9%), age group 21-35 years (53.8%), and non-doctors/nurses (60.8%). The significant influencing factors in multivariate analysis were age group 36-45 years (p = 0.04), nursing proffesion (p = 0.005), and non- viral-based baccine type (p = < 0.0001).
Conclusion: Neurological AEFI is commonly found among the health workforce who received the COVID-19 vaccination. However, it only has a little impact on their work and attitudes towards vaccination. This may be because all subjects experienced mild neurological AEFI.
Ministry of Health of the Republic of Indonesia. Keputusan Menteri Kesehatan No. HK.01.07/MENKES/4638/2021 Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi COVID-19; 2021. p. 1–157.
D’Souza G, Dowdy D. What is herd immunity and how can we achieve it with covid-19?; 2021.
Available from: https://www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html
WHO. Vaccine safety basics electronic training (module 3 post-immunization adverse events); 2021. Available from: https://in.vaccine-safety- training.org/classification-of-aefis.html
García-Grimshaw M, Ceballos-Liceaga SE, Hernández-Vanegas LE, et al. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study. Clin Immunol; 2021. 229(January). DOI: 10.1016/J.CLIM.2021.108786
World Health Organization. [Homepage on the internet]. Global manual on surveillance of adverse events following immunization; 2016. Available from: https://apps.who.int/iris/handle/10665/206144
Tran VN, An H, Thanh T, Le A, et al. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021; 2020. DOI : 10.1016/j.vaccine.2021.09.060.
Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): A single-blind, randomised, controlled, phase 2/3 trial. Lanset; 2020. 396(10267):1979–1993. DOI: 10.1016/S0140-6736(20)32466-1
Endaryanto A. Mengenal isi vaksin covid-19 dan respons tubuh manusia terhadapnya (fokus pada inactivated sars-cov-2 vaccine); 2021. Available from : https://rsudrsoetomo.jatimprov.go.id/wp-content/uploads/2021/01/dr_anang.pdf
Yanjun Z, Et.al. Immunogenicity and safety of a sars- cov-2 inactivated vaccine in healthy adults aged 18-59 years: Report of the randomized, double-blind, and placebo-controlled phase 2 clinical trial. medRxiv; 2020. DOI : 10.1016/s1473-3099(20)30843-4
Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus Res; 2020. 288(198114). DOI: 10.1016/j.virusres.2020.198114
Bellavite P. Causality assessment of adverse events following immunization: The problem of multifactorial pathology. F1000 Research; 2020. 9.
Handayani S, Fannya P, Nazofah P. faktor yang berhubungan dengan kinerja tenaga kesehatan di rawat inap RSUD Batusangkar. J Endur; 2018. 3(3):440.
Shrestha S, Devbhandari RP, Shrestha A, et al. Adverse events following the first dose of ChAdOx1 nCoV-19 (COVISHIELD) vaccine in the first phase of vaccine roll out in Nepal. J Patan Acad Heal Sci; 2021. 8(1):9–17. DOI: 10.3126/jpahs.v8i1.36242
Paris C, Benezit F, Geslin M, et al. Covid-19 vaccine hesitancy among healthcare workers; 2021. (1).
How to Cite
Copyright (c) 2022 MNJ (Malang Neurology Journal)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License